Natalie Fitzgerald

1.0k total citations · 1 hit paper
26 papers, 618 citations indexed

About

Natalie Fitzgerald is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Natalie Fitzgerald has authored 26 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Natalie Fitzgerald's work include Global Cancer Incidence and Screening (12 papers), Colorectal Cancer Screening and Detection (10 papers) and Cervical Cancer and HPV Research (5 papers). Natalie Fitzgerald is often cited by papers focused on Global Cancer Incidence and Screening (12 papers), Colorectal Cancer Screening and Detection (10 papers) and Cervical Cancer and HPV Research (5 papers). Natalie Fitzgerald collaborates with scholars based in Canada, United Kingdom and United States. Natalie Fitzgerald's co-authors include Beverley M. Essue, Claire de Oliveira, Nicolas Iragorri, Donna Turner, Christian Finley, Nathalie Saint‐Jacques, Darren R. Brenner, Larry F. Ellison, Lorraine Shack and Ryan Woods and has published in prestigious journals such as British Journal of Cancer, Gynecologic Oncology and Canadian Medical Association Journal.

In The Last Decade

Natalie Fitzgerald

26 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Projected estimates of cancer in Canada in 2022

2022 184 citations Darren R. Brenner, Abbey E. Poirier et al. Canadian Medical Association Journal profile →

Peers

Countries citing papers authored by Natalie Fitzgerald

Since Specialization

Citations

This map shows the geographic impact of Natalie Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Fitzgerald more than expected).

Fields of papers citing papers by Natalie Fitzgerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Fitzgerald. The network helps show where Natalie Fitzgerald may publish in the future.

Co-authorship network of co-authors of Natalie Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Fitzgerald. A scholar is included among the top collaborators of Natalie Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Fitzgerald. Natalie Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Projected estimates of cancer in Canada in 2024 2024 ·Canadian Medical Association Journal ·Darren R. Brenner, Jennifer Gillis, Alain Demers, Larry F. Ellison, Jean‐Michel Billette, (unknown), (unknown), Ryan Woods, Christian Finley, Natalie Fitzgerald, Nathalie Saint‐Jacques, Lorraine Shack, Donna Turner	46
2	Projected estimates of cancer in Canada in 2022 breakdown → 2022 ·Canadian Medical Association Journal ·Darren R. Brenner, Abbey E. Poirier, Ryan Woods, Larry F. Ellison, Jean‐Michel Billette, Alain Demers, (unknown), (unknown), Christian Finley, Natalie Fitzgerald, Nathalie Saint‐Jacques, Lorraine Shack, Donna Turner, Elizabeth Holmes	184
3	Update on cancer incidence trends in Canada, 1984 to 2017 2022 ·Health Promotion and Chronic Disease Prevention in Canada ·Alain Demers, Nathalie Saint‐Jacques, Larry F. Ellison, Darren R. Brenner, Natalie Fitzgerald, (unknown), Donna Turner	3
4	The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review 2021 ·Current Oncology ·Nicolas Iragorri, Claire de Oliveira, Natalie Fitzgerald, Beverley M. Essue	106
5	The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review 2020 ·Applied Health Economics and Health Policy ·Nicolas Iragorri, Claire de Oliveira, Natalie Fitzgerald, Beverley M. Essue	29
6	The psychosocial cost burden of cancer: A systematic literature review 2020 ·Psycho-Oncology ·Beverley M. Essue, Nicolas Iragorri, Natalie Fitzgerald, Claire de Oliveira	40
7	Moving toward the Elimination of Cervical Cancer: Modelling the Health and Economic Benefits of Increasing Uptake of Human Papillomavirus Vaccines 2019 ·Current Oncology ·Alison Smith, (unknown), S. Memon, Natalie Fitzgerald, (unknown), (unknown), Emily Nicholson, Craig C. Earle, Heather Bryant	16
8	MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience 2018 ·Journal of Thoracic Oncology ·William S. Evans, W. Michael Flanagan, Cindy L. Gauvreau, Phongsack Manivong, (unknown), Natalie Fitzgerald, John R. Goffin, Rochelle Garner, Edmund Khoo, Nicole Mittmann	2
9	A randomised controlled trial of an advance care planning intervention for patients with incurable cancer 2018 ·British Journal of Cancer ·Stephanie Johnson, Phyllis Butow, Melanie L. Bell, Karen Detering, Josephine M. Clayton, William Silvester, Belinda E. Kiely, Stephen Clarke, L. Vaccaro, Martin R. Stockler, Philip Beale, Natalie Fitzgerald, Martin H.N. Tattersall	56
10	Evaluating Clinical and Cost Impacts of Achieving 90% HPV Vaccination Rate Against Cervical Cancer in Canada Using the OncoSim Cancer Simulation Model 2018 ·Journal of Global Oncology ·Natalie Fitzgerald, (unknown), S. Memon, Cindy L. Gauvreau, W. Michael Flanagan, (unknown), (unknown), Anthony B. Miller, Andrew J. Coldman, Catherine Popadiuk	1
11	OA17.02 Potential Health and Economic Consequences of Organized vs Opportunistic Lung Cancer Screening in Canada 2017 ·Journal of Thoracic Oncology ·William K. Evans, Cindy L. Gauvreau, S. Memon, John R. Goffin, Jason Lacombe, (unknown), Natalie Fitzgerald, Anthony B. Miller	1
12	Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model 2017 ·Journal of Cancer Policy ·Andrew J. Coldman, Joy Pader, Cindy L. Gauvreau, S. Memon, Natalie Fitzgerald, W. Michael Flanagan, (unknown), Craig C. Earle, Michael Wolfson, Anthony B. Miller, Jason Lacombe	10
13	Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model 2017 ·Journal of Cancer Policy ·Andrew J. Coldman, W. Michael Flanagan, (unknown), Michael Wolfson, Natalie Fitzgerald, S. Memon, Cindy L. Gauvreau, Anthony B. Miller, Craig C. Earle	11
14	OA 06.01 Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening Program 2017 ·Journal of Thoracic Oncology ·William K. Evans, Cindy L. Gauvreau, W. Michael Flanagan, S. Memon, Natalie Fitzgerald, John R. Goffin, Andrea Miller	1
15	Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) 2016 ·Gynecologic Oncology ·Cathy Popadiuk, A J Coldman, S. Memon, Natalie Fitzgerald, (unknown), Gina Lockwood, (unknown), Anthony B. Miller	1
16	Implementing Low-Dose Computed Tomography Screening for Lung Cancer in Canada: Implications of Alternative At-Risk Populations, Screening Frequency, and Duration 2016 ·Current Oncology ·William K. Evans, W. Michael Flanagan, Anthony B. Miller, John R. Goffin, S. Memon, Natalie Fitzgerald, Michael Wolfson	11
17	Using the Cancer Risk Management Model to Evaluate the Health and Economic Impacts of Cytology Compared with Human Papillomavirus DNA Testing for Primary Cervical Cancer Screening in Canada 2016 ·Current Oncology ·Cathy Popadiuk, Cindy L. Gauvreau, (unknown), (unknown), (unknown), W. Michael Flanagan, Michael Wolfson, Andrew J. Coldman, S. Memon, Natalie Fitzgerald, Jason Lacombe, Anthony B. Miller	9
18	Using the Cancer Risk Management Model to Evaluate Colorectal Cancer Screening Options for Canada 2015 ·Current Oncology ·Andrew J. Coldman, Natasha Phillips, Jacques Brisson, W. Michael Flanagan, Michael Wolfson, (unknown), Natalie Fitzgerald, Anthony B. Miller	29
19	Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM) – Human papillomavirus and cervical components 2015 ·Journal of Cancer Policy ·Anthony B. Miller, Steven D. Gribble, (unknown), (unknown), W. Michael Flanagan, Michael Wolfson, Andrew J. Coldman, William K. Evans, Natalie Fitzgerald, Gina Lockwood, Cathy Popadiuk	8
20	Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study 2012 ·Journal of the Pediatric Infectious Diseases Society ·S. P. Georgiadou, Georgios Pongas, Natalie Fitzgerald, Russell E. Lewis, Michael Rytting, Edith M. Marom, D. P. Kontoyiannis	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact